Evidence map›Paper›PMID 35637506›Full record

Observational studyMalaria journal2022

Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.

Jean Moise Tanga Kaboré, Mohamadou Siribié, Denise Hien, Issiaka Soulama, Nouhoun Barry, Yacouba Nombré, Frederic Dianda, Adama Baguiya, Alfred Bewendtaoré Tiono, Christian Burri and 2 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Malaria journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04265573 (Feasibility, Acceptability and Costs of a Strategy Deploying Multiple First-lines Artemisinin-based Combination Therapies for Uncomplicated Malaria), which is not on this map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04265573 completednot on this map

Feasibility, Acceptability and Costs of a Strategy Deploying Multiple First-lines Artemisinin-based Combination Therapies for Uncomplicated Malaria: a Pilot Programme in the Health District of Kaya, Burkina Faso

TypeobservationalSponsorGroupe de Recherche Action en SanteRan2018 to 2021Enrolled150,000ConditionsMalaria
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jean Moise Tanga KaboréGroupe de Recherche Action en Santé (GRAS), P.O Box 10248, Ouagadougou 06, Burkina Faso. m.kabore@gras.bf.ORCID http://orcid.org/0000-0002-8560-2507
Mohamadou SiribiéInternational Vaccine Institute (IVI), Seoul, Republic of Korea.
Denise HienGroupe de Recherche Action en Santé (GRAS), P.O Box 10248, Ouagadougou 06, Burkina Faso.
Issiaka SoulamaGroupe de Recherche Action en Santé (GRAS), P.O Box 10248, Ouagadougou 06, Burkina Faso.
Nouhoun BarryGroupe de Recherche Action en Santé (GRAS), P.O Box 10248, Ouagadougou 06, Burkina Faso.
Yacouba NombréProgramme National de Lutte contre le Paludisme, Ouagadougou, Burkina Faso.
Frederic DiandaProgramme National de Lutte contre le Paludisme, Ouagadougou, Burkina Faso.
Adama BaguiyaKaya Health and Demographic Surveillance System (Kaya-HDSS), Institut de Recherche en Sciences de la Santé (IRSS), Ouagadougou, Burkina Faso.
Alfred Bewendtaoré TionoGroupe de Recherche Action en Santé (GRAS), P.O Box 10248, Ouagadougou 06, Burkina Faso.
Christian BurriSwiss Tropical and Public Health Institute, Basel, Switzerland.
André-Marie TchouatieuMedicines for Malaria Venture (MMV), Geneva, Switzerland.
Sodiomon Bienvenu SirimaGroupe de Recherche Action en Santé (GRAS), P.O Box 10248, Ouagadougou 06, Burkina Faso.

Funding

Medicines for Malaria Venture PO18/00879
6 · The paper itself

Abstract

backgroundMalaria case management relies on World Health Organization (WHO)-recommended artemisinin-based combination therapy (ACT), and a continuous understanding of local community knowledge, attitudes, and practices may be a great support for the success of malaria disease control efforts. In this context, this study aimed to identify potential facilitators or barriers at the community level to inform a health district-wide implementation of multiple first-line therapies (MFT) as a new strategy for uncomplicated malaria case management.

methodsA community-based cross-sectional study using a mixed-method design was carried out from November 2018 to February 2019, in the health district (HD) of Kaya in Burkina Faso. Quantitative data were collected using a standardized questionnaire from 1394 individuals who had fever/malaria episodes four weeks prior to the survey. In addition, 23 focus group discussions (FGDs) were conducted targeting various segments of the community. Logistic regression models were used to assess the predictors of community care-seeking behaviours.

resultsOverall, 98% (1366/1394) of study participants sought advice or treatment, and 66.5% did so within 24 h of fever onset. 76.4% of participants preferred to seek treatment from health centres as the first recourse to care, 5.8% were treated at home with remaining drug stock, and 2.3% preferred traditional healers. Artemether-lumefantrine (AL) was by far the most used anti-malarial drug (98.2%); reported adherence to the 3-day treatment regimen was 84.3%. Multivariate analysis identified less than 5 km distance travelled for care (AOR = 2.7; 95% CI 2.1-3.7) and education/schooling (AOR = 1.8; 95% CI 1.3-2.5) as determinants of prompt care-seeking for fever. Geographical proximity (AOR = 1.5, 95% CI 1.2-2.1), having a child under five (AOR = 4.6, 95% CI 3.2-6.7), being pregnant (AOR = 6.5, 95% CI 1.9-22.5), and living in an urban area (AOR = 2.8, 95% CI 1.8-4.2) were significant predictors for visiting health centres. The FGDs showed that participants had good knowledge about malaria symptoms, prevention tools, and effective treatment. Behaviour change regarding malaria treatment and free medication for children under five were the main reasons for participants to seek care at health centres.

conclusionsThe study showed appropriate knowledge about malaria and positive community care-seeking behaviour at health centres for fever/malaria episodes. This could potentially facilitate the implementation of a MFT pilot programme in the district. CLINICALTRIALS: gov Identifier: NCT04265573.

Indexed as

AntimalarialsMalariaArtemetherArtemether, Lumefantrine Drug CombinationBurkina FasoChildCross-Sectional StudiesFemaleFeverHumansPatient Acceptance of Health CarePregnancyAntimalarialsArtemetherArtemether, Lumefantrine Drug CombinationBurkina FasoCare-seeking behaviourMalariaMultiple first-line therapies

Identifiers

PMID35637506
PMCPMC9153091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.